Ministerio
ISCIII ISCIII CNIO CNIC
Repisalud
JavaScript is disabled for your browser. Some features of this site may not work without it.
Home
About Repisalud
  • Authors Info  
    • Autoarchive guideAutoarchive guide
    • CopyrightCopyright
    • Creative CommonsCreative Commons
    • PoliciesPolicies
FAQs
Login
Contact / Suggestions
  • English 
    • español
    • English
helpAdvanced search

Browse

All of RepisaludCommunities and CollectionsBy Issue DateAuthorsTitlesDocument typeInstitutionSubjectsMeSHFunding agenciesThis CommunityBy Issue DateAuthorsTitlesDocument typeInstitutionSubjectsMeSHFunding agencies

Discover

AuthorInstituto de Salud Carlos III. Gabinete de prensa (1)Date Issued2021 (1)Tipoother (1)
video (1)
InstituciónISCIII (1)

Statistics

Home
About Repisalud
  • Authors Info  
    • Autoarchive guideAutoarchive guide
    • CopyrightCopyright
    • Creative CommonsCreative Commons
    • PoliciesPolicies
FAQs
Login
Contact / Suggestions
  • English 
    • español
    • English
helpAdvanced search
Search 
  •   Repisalud Home
  • Institutional
  • ISCIII
  • Covid-19
  • Search
  •   Repisalud Home
  • Institutional
  • ISCIII
  • Covid-19
  • Search

Search

Show Advanced FiltersHide Advanced Filters

Filters

Use filters to refine the search results.

  • Sort Options:
  • Relevance
  • Title Asc
  • Title Desc
  • Issue Date Asc
  • Issue Date Desc
  • submit date Asc
  • submit date Desc
  • Results Per Page:
  • 5
  • 10
  • 20
  • 40
  • 60
  • 80
  • 100

Now showing items 1-1 of 1

Rights
Preview
Issue Date
Title
Type
Author(s)
Acceso Abierto
Thumbnail
2021-05-18

El uso combinado de las vacunas de AstraZeneca y Pfizer contra el SARS-CoV-2 ofrece una potente respuesta inmunitaria

 

othervideo

Instituto de Salud Carlos III. Gabinete de prensa

REPISALUD - REPositorio Institucional de SALUD © 2017 Ministerio de Ciencia e Innovación

AccesibilityRSSContact
RSS FeedRSS FeedRSS Feed
by-nc-sa
DSpace